Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention
The Journal of Tehran University Heart Center · 11.10.2022
DOI: 10.18502/jthc.v17i3.10844 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Tehran University Heart Center, online erschienen am 11.10.2022. Verfasst von Saeedeh Asgarbeik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehra…. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In-stent restenosis (ISR) is an inevitable complication of percutaneous coronary intervention, with genetic factors thought to play a role in its pathogenesis. The VEGF gene can have an inhibitory effect on ISR development. Accordingly, in the present study, we investigated the role of −2549 VEGF (insertion/deletion [I/D]) variants in ISR formation.
Methods
Patients with ISR (ISR+) (n=53) and patients without ISR (ISR-) (n=67) were enrolled in this case-control study based on follow-up angiography 1 year after percutaneous coronary intervention between 2019 and 2020. The clinical characteristics of the patients were evaluated, and the frequencies of the alleles and genotypes of −2549 VEGF (I/D) variants were determined using polymerase chain reaction. The χ2 test was performed for the calculation of genotypes and alleles. A P value of less than 0.05 was considered the level of significance.
Results
This study recruited 120 individuals at a mean age of 61.43±8.91 years in the ISR+ group and 62.09±7.94 years in the ISR- group. Women and men, respectively, comprised 26.4% and 73.6% of the ISR+ group and 43.3% and 56.7% of the ISR- group. A significant association was observed between the VEGF −2549 genotype frequency and ISR. The frequency of the insertion/insertion (I/I) allele was significantly higher in the ISR+ group than in the ISR- group, while the frequency of the D/D allele was higher in the latter group.
Conclusion
Regarding ISR development, the I/I allele may be a risk allele and the D/D allele a protective allele.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Asgarbeik, S., Vahidi, A., Hasanzad, M., Asadi, M., & Mohammad Amoli, M. (2022). Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention. The Journal of Tehran University Heart Center. https://doi.org/10.18502/jthc.v17i3.10844
Vancouver
Asgarbeik S, Vahidi A, Hasanzad M, Asadi M, Mohammad Amoli M. Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention. The Journal of Tehran University Heart Center. 2022. doi:10.18502/jthc.v17i3.10844
BibTeX
@article{Asgarbeik2022,
author = {Asgarbeik, Saeedeh and Vahidi, Aida and Hasanzad, Mandana and Asadi, Mojgan and Mohammad Amoli, Mahsa},
title = {Vascular Endothelial Growth Factor Genetic Variant is Associated with In-Stent Restenosis after Percutaneous Coronary Intervention},
journal = {The Journal of Tehran University Heart Center},
year = {2022},
doi = {10.18502/jthc.v17i3.10844}
}
EUVIMED